RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Valeant Pharmaceuticals International

A collection of news and information related to Valeant Pharmaceuticals International published by this site and its partners.

Top Valeant Pharmaceuticals International Articles see all

Displaying items 1-5
  • Valeant agrees to buy Salix for about $10 billion in cash

    Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash.
  • Pharmaceutical giant Actavis plans to rename itself Allergan

    Pharmaceutical giant Actavis plans to rename itself Allergan
    Irish pharmaceutical company Actavis said it will adopt the Allergan name after closing a deal to buy the Irvine Botox maker. In November, Actavis agreed to pay about $66 billion in cash and stock to acquire Allergan, outbidding Canadian company Valeant...

    Dendreon shares drop 71 percent

    SEATTLE Shares of Dendreon fell 71 percent to a nickel Wednesday morning, evidently reflecting speculators' dashed hopes that bidding for the bankrupt Seattle biotechnology company would result in some value for stockholders. The company announced...

    Valeant wins Dendreon with $400M bid

    SEATTLE No rival bidder has topped Valeant Pharmaceuticals International's bid of $400 million for the assets of Dendreon, and an auction scheduled for Thursday has been canceled, the Seattle biotechnology company said Tuesday. Instead, a bankruptcy...

    Allergan sets up meeting to seek shareholder OK of Actavis acquisition

    Allergan Inc., the Irvine company that makes Botox, scheduled a March 10 special meeting to seek shareholder approval of its acquisition by Irish firm Actavis. Actavis agreed in November to pay about $66 billion in cash and stock to acquire Allergan,...